TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11865745

Group type: EXPERIMENTAL
Intervention: Multimodality educational session (60 minutes)
Number of subjects: 39
Study: 10522283

Group type: EXPERIMENTAL
Intervention: Overlapping group (O)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sequential group (S)
Number of subjects: 40
Study: 8770718

Group type: EXPERIMENTAL
Intervention: Adequate antidepressant treatment (dosage not specified)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Low-intensity antidepressant treatment (dosage not specified)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Low-intensity treatment
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Higher-intensity treatment
Number of subjects: 88
Study: 2292546

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Intraperitoneal vancomycin/netilmicin
Number of subjects: 35
Study: 7006619

Group type: EXPERIMENTAL
Intervention: Propranolol, given four times daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Penbutolol, given once daily
Number of subjects: 14
Study: 31614329

Group type: EXPERIMENTAL
Intervention: Tart Cherry Juice (TCJ)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20
Study: 29860661

Group type: EXPERIMENTAL
Intervention: 1500 mg vitamin C daily 2 days after RAIT
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 1500 mg vitamin C daily 2 days before to 2 days after RAIT
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 1500 mg vitamin C daily 2 days before RAIT
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (RAIT without vitamin C)
Number of subjects: 58
Study: 28450772

Group type: EXPERIMENTAL
Intervention: Bupivacaine + Dexmedetomidine (Group D)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Bupivacaine + Normal Saline (Group C)
Number of subjects: 70
Study: 24200715

Group type: EXPERIMENTAL
Intervention: Permanent and intermittent atrioventricular (AV) block
Number of subjects: 1808

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation with slow ventricular rate
Number of subjects: 1808

Group type: EXPERIMENTAL
Intervention: Miscellaneous bradyarrhythmias
Number of subjects: 1808

Group type: EXPERIMENTAL
Intervention: Left bundle branch block
Number of subjects: 1808

Group type: EXPERIMENTAL
Intervention: Atrial tachyarrhythmias
Number of subjects: 1808
Study: 21822593

Group type: EXPERIMENTAL
Intervention: THC (Δ(9)‐tetrahydrocannabinol)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 20093335

Group type: EXPERIMENTAL
Intervention: Subzero-balanced ultrafiltration
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine cardiopulmonary bypass
Number of subjects: 120
Study: 17192497

Group type: EXPERIMENTAL
Intervention: 15 mg intranasal ketorolac
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 30 mg intranasal ketorolac
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 15 mg intramuscular ketorolac
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 30 mg intramuscular ketorolac
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intranasal ketorolac (both doses)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intranasal ketorolac
Number of subjects: 15
Study: 15292384

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (MeCCNU, vincristine, 5-fluorouracil)
Number of subjects: 1166

Group type: COMPARATOR
Intervention: Adjuvant immunotherapy (bacillus Calmette‐Guérin)
Number of subjects: 1166

Group type: EXPERIMENTAL
Intervention: Surgery alone
Number of subjects: 1166
Study: 11800507

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg 5 nights/week
Number of subjects: 789

Group type: COMPARATOR
Intervention: Placebo 2 nights/week
Number of subjects: 789
Study: 10526810

Group type: EXPERIMENTAL
Intervention: Propofol (1, 2, 3, 4, 5, or 6 micrograms/ml) and Sufentanil (0.1, 0.2, 0.3, 0.5, or 1.0 ng/ml) target blood concentrations
Number of subjects: 30
Study: 7677489

Group type: EXPERIMENTAL
Intervention: Limited resection (segment or wedge)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 247
Study: 2264951

Group type: EXPERIMENTAL
Intervention: Baclofen 40 mg/day
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Baclofen 80 mg/day
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 5
Study: 375802

Group type: EXPERIMENTAL
Intervention: Cefazolin, 1 gm intramuscularly preoperatively, then 0.5 gm every six hours for four doses
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 31705685

Group type: EXPERIMENTAL
Intervention: Head-tail rope assistance (group A)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Unassisted recovery (group U)
Number of subjects: 301
Study: 31815615

Group type: EXPERIMENTAL
Intervention: Clinic-based self-sampling
Number of subjects: 3550

Group type: EXPERIMENTAL
Intervention: Mail-out self-sampling
Number of subjects: 3550

Group type: COMPARATOR
Intervention: Usual care (clinician-collected cytology test)
Number of subjects: 3550
Study: 28866743

Group type: COMPARATOR
Intervention: 20 mg THC
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 25528432

Group type: EXPERIMENTAL
Intervention: High-oleic canola oil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Corn/safflower oil
Number of subjects: 50

Group type: COMPARATOR
Intervention: DHA-enriched high oleic canola oil
Number of subjects: 50
Study: 23656989

Group type: EXPERIMENTAL
Intervention: Microglial response to dense-core plaques
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Astrocytic response to dense-core plaques
Number of subjects: 40
Study: 21385856

Group type: EXPERIMENTAL
Intervention: oral 6‐mercaptopurine and intramuscular methotrexate (arm 1)
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: ATRA alone (arm 2)
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: 3 months of arm 1 alternating to 15 days of arm 2 (arm 3)
Number of subjects: 807

Group type: COMPARATOR
Intervention: no further therapy (arm 4)
Number of subjects: 807
Study: 19106352

Group type: EXPERIMENTAL
Intervention: MCA training module
Number of subjects: 6
Study: 16472976

Group type: EXPERIMENTAL
Intervention: Branched-chain-enriched amino acid mixture infused at 82 mg x h(‐1) x kg(‐1) for 3 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balanced amino acid infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Branched-chain-enriched amino acid mixture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balanced amino acid mixture
Number of subjects: 0
Study: 10809242

Group type: EXPERIMENTAL
Intervention: 2.0 L dialysate fill volume
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 2.5 L dialysate fill volume
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 3.0 L dialysate fill volume
Number of subjects: 81
Study: 8752629

Group type: EXPERIMENTAL
Intervention: 0.5 mg of dexamethasone
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 99
Study: 1846981

Group type: EXPERIMENTAL
Intervention: Carboplatin/etoposide/vincristine (CEV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etoposide/vincristine
Number of subjects: 0
Study: 6340970

Group type: EXPERIMENTAL
Intervention: 600 mg tiaprofenic acid daily for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: 100 mg indomethacin daily for 3 months
Number of subjects: 60
Study: 31585976

Group type: EXPERIMENTAL
Intervention: Emergency caesarean delivery
Number of subjects: 347

Group type: COMPARATOR
Intervention: Elective caesarean delivery
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Future mode of birth preference
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Willingness to participate in a randomised trial
Number of subjects: 347
Study: 30025937

Group type: EXPERIMENTAL
Intervention: Communication intervention
Number of subjects: 537
Study: 27038153

Group type: EXPERIMENTAL
Intervention: Action Observation + Repeated Practice (AO+RP)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Repeated Practice (RP) alone
Number of subjects: 70
Study: 24785926

Group type: EXPERIMENTAL
Intervention: Light-cured glass ionomer cement (Transbond Plus Light Cure Band Adhesive; 3M Unitek) bonded onto the occlusal surface of the mandibular first premolar for 4 weeks.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no intervention on one side of each patient).
Number of subjects: 12
Study: 23009579

Group type: EXPERIMENTAL
Intervention: Dementia Quality of life Instrument (DQI)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: DQI
Number of subjects: 145
Study: 20003116

Group type: EXPERIMENTAL
Intervention: Oxygen (inspired O(2) fraction 0.80)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Medical air (inspired O(2) fraction 0.21)
Number of subjects: 9
Study: 18160927

Group type: EXPERIMENTAL
Intervention: Point injection
Number of subjects: 69

Group type: COMPARATOR
Intervention: Traditional acupuncture
Number of subjects: 69
Study: 16336289

Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation Programme (PRP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tiotropium therapy alone (Control)
Number of subjects: 50
Study: 12208407

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG-tilt)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Passive tilt
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Isoproterenol (ISO-tilt)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG-tilt) in patients with positive passive tilt response
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Isoproterenol (ISO-tilt) in patients with positive passive tilt response
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG-tilt) in patients with negative passive tilt response
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Isoproterenol (ISO-tilt) in patients with negative passive tilt response
Number of subjects: 96
Study: 10688525

Group type: EXPERIMENTAL
Intervention: Five consecutive trials of hyperventilation with cognitive restructuring instructions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Five consecutive trials of voluntary hyperventilation
Number of subjects: 0
Study: 7602022

Group type: EXPERIMENTAL
Intervention: Outpatient consultative geriatric assessment
Number of subjects: 442
Study: 31016610

Group type: EXPERIMENTAL
Intervention: Acceptance
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Reappraisal
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control
Number of subjects: 105
Study: 31194943

Group type: EXPERIMENTAL
Intervention: Early clinical assessment of dysphagia before oral intake; therapeutic interventions implemented immediately for diagnosed dysphagia
Number of subjects: 438

Group type: COMPARATOR
Intervention: Control group (no early assessment of dysphagia)
Number of subjects: 438
Study: 28244408

Group type: EXPERIMENTAL
Intervention: GemX (gemcitabine chemotherapy at 100 mg/m2 with concurrent radiation therapy at a total dose of 52.5 Gy in 20 fractions)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: neoGemX (gemcitabine chemotherapy at 100 mg/m2 with concurrent radiation therapy at a total dose of 52.5 Gy in 20 fractions following NAC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: GemX
Number of subjects: 78

Group type: COMPARATOR
Intervention: neoGemX
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: GemX and neoGemX
Number of subjects: 78
Study: 26718518

Group type: EXPERIMENTAL
Intervention: Triple therapy with clopidogrel (triple-C)
Number of subjects: 11756

Group type: EXPERIMENTAL
Intervention: Triple therapy with prasugrel (triple-P)
Number of subjects: 11756

Group type: COMPARATOR
Intervention: Dual therapy with clopidogrel (dual-C)
Number of subjects: 11756

Group type: COMPARATOR
Intervention: Dual therapy with prasugrel (dual-P)
Number of subjects: 11756

Group type: EXPERIMENTAL
Intervention: Triple therapy (both triple-C and triple-P)
Number of subjects: 11756
Study: 22892368

Group type: EXPERIMENTAL
Intervention: Multi-sugar (MS) test (1 g sucrose, lactulose, sucralose, erythritol, 0.5 g rhamnose in water) after indomethacin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dual sugar (DS) test (5 g lactulose, 0.5 g rhamnose) after indomethacin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both MS and DS tests after indomethacin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Multi-sugar (MS) test
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dual sugar (DS) test
Number of subjects: 10
Study: 21193619

Group type: EXPERIMENTAL
Intervention: Telephonic intervention
Number of subjects: 526

Group type: COMPARATOR
Intervention: Print intervention
Number of subjects: 526
Study: 19059855

Group type: EXPERIMENTAL
Intervention: Intensive Case Management (ICM)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Usual Care (screen-and-refer program)
Number of subjects: 302
Study: 17313722

Group type: EXPERIMENTAL
Intervention: Healthy meal course (2090 kJ/meal)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control meal (2090 kJ/meal)
Number of subjects: 13
Study: 15471656

Group type: EXPERIMENTAL
Intervention: Dexamethasone (20 mg/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 11915694

Group type: EXPERIMENTAL
Intervention: Orthoptic exercises and near point exercises at home (Group 1, 34 patients)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Only near point exercises at home (Group 2, 34 patients)
Number of subjects: 162

Group type: COMPARATOR
Intervention: No treatment (Control Group 3, 30 patients)
Number of subjects: 162
Study: 9876450

Group type: EXPERIMENTAL
Intervention: Blood samples drawn from femoral and brachial veins after 30 minutes in reverse Trendelenburg position
Number of subjects: 19
Study: 7976142

Group type: EXPERIMENTAL
Intervention: 40 ml 0.5% lidocaine with 2 mg of atracurium
Number of subjects: 40

Group type: COMPARATOR
Intervention: 40 ml 0.5% lidocaine
Number of subjects: 40
Study: 2597711

Group type: EXPERIMENTAL
Intervention: Current feedback (accurate information regarding blood glucose levels)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Noncurrent feedback (blood glucose levels from the preceding session)
Number of subjects: 36
Study: 1020593

Group type: EXPERIMENTAL
Intervention: Heineke-Mikulicz (HM) pyloroplasty
Number of subjects: 170

Group type: COMPARATOR
Intervention: Finney (F) pyloroplasty
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 170
Study: 30789546

Group type: EXPERIMENTAL
Intervention: Parent meetings attendance
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Preschooler letters
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Preschooler program attendance
Number of subjects: 39
Study: 27783162

Group type: EXPERIMENTAL
Intervention: Subcutaneous closed-suction drainage arm
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control arm (no subcutaneous drainage)
Number of subjects: 240
Study: 26636533

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Group D)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Remifentanil (Group R)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 70
Study: 22960239

Group type: EXPERIMENTAL
Intervention: Intermittent traction
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Continuous traction
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (hot pack and short wave diathermy)
Number of subjects: 98
Study: 21519837

Group type: EXPERIMENTAL
Intervention: CEF adjuvant chemotherapy
Number of subjects: 477

Group type: COMPARATOR
Intervention: CMF adjuvant chemotherapy
Number of subjects: 477
Study: 18370574

Group type: EXPERIMENTAL
Intervention: Aripiprazole (5-30 mg/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 16565827

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (7 or 14 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 14514591

Group type: EXPERIMENTAL
Intervention: HYAFF 11-based autologous dermal and epidermal grafts
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nonadherent paraffin gauze (Control)
Number of subjects: 79
Study: 11090796

Group type: EXPERIMENTAL
Intervention: 60-minute determination of ST-segment resolution after thrombolytic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: 90-minute determination of ST-segment resolution after thrombolytic therapy
Number of subjects: 0
Study: 8937904

Group type: EXPERIMENTAL
Intervention: Psychiatric consultation intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no psychiatric consultation)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intervention group (psychiatric consultation)
Number of subjects: 104
Study: 1526219

Group type: EXPERIMENTAL
Intervention: 3,4-diaminopyridine
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: 3,4-diaminopyridine + anti-cholinesterase medication
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 2989052

Group type: EXPERIMENTAL
Intervention: 40 g bran daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no dietary supplement)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Dropouts (bran group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Refusers (bran group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Participants (bran group)
Number of subjects: 200
Study: 31501094

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 94
Study: 29126173

Group type: EXPERIMENTAL
Intervention: Inactivated poliovirus vaccine (IPV) at all time points (Arm A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bivalent oral poliovirus vaccine (bOPV) at all time points (Arm B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: bOPV at first 3 time points and bOPV plus IPV at final time point (Arm C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: bOPV at first 3 time points and bOPV plus IPV at final time point (Arm D)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trivalent OPV (tOPV) at all time points (Arm E)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inactivated poliovirus vaccine (IPV) at final time point (Arm D)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 26983976

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (once-per-day)
Number of subjects: 400

Group type: COMPARATOR
Intervention: No topical corticosteroids
Number of subjects: 400
Study: 24671338

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (sensitising dosage pattern)
Number of subjects: 0
Study: 22464810

Group type: EXPERIMENTAL
Intervention: Golden Delicious apple juice (300 mL)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Catarina apple juice (300 mL)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 9
Study: 19827166

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (LS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Structured education (control)
Number of subjects: 31
Study: 17823908

Group type: EXPERIMENTAL
Intervention: Docetaxel/gemcitabine (docetaxel 30 mg/m(2) + gemcitabine 800 mg/m(2))
Number of subjects: 350

Group type: COMPARATOR
Intervention: Weekly docetaxel (36 mg/m(2))
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Docetaxel/gemcitabine
Number of subjects: 350

Group type: COMPARATOR
Intervention: Weekly docetaxel
Number of subjects: 350
Study: 15339495

Group type: EXPERIMENTAL
Intervention: Conventional steroid plus kidney-warming and astringent therapy (treatment group)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional steroid treatment (control group)
Number of subjects: 44
Study: 11691528

Group type: EXPERIMENTAL
Intervention: Dual-chamber pacemaker implant (paced patients)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Standard treatment (controls)
Number of subjects: 175
Study: 9647418

Group type: EXPERIMENTAL
Intervention: BMT-plus-RP
Number of subjects: 59

Group type: COMPARATOR
Intervention: BMT-only
Number of subjects: 59
Study: 8016038

Group type: EXPERIMENTAL
Intervention: Mail-out intervention for increasing screening mammography rates
Number of subjects: 802

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Combined intervention and control group
Number of subjects: 802
Study: 2801831

Group type: EXPERIMENTAL
Intervention: Danazol (600 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (100 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative surgery plus danazol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative surgery plus medroxyprogesterone acetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative surgery plus placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mild endometriosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Advanced endometriosis
Number of subjects: 0
Study: 49745

Group type: EXPERIMENTAL
Intervention: Long 'Teflon' cannulas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Butterfly stainless steel cannulas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent short duration intravenous infusions
Number of subjects: 0
Study: 31376356

Group type: EXPERIMENTAL
Intervention: Maltodextrin-based feed with lysozyme product (Inovapure) at 20 g/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Maltodextrin-based feed with lysozyme product (Inovapure) at 10 g/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Maltodextrin-based feed with lysozyme product (Inovapure) at 0 g/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional feed withdrawal
Number of subjects: 20
Study: 29529607

Group type: EXPERIMENTAL
Intervention: Ankle block added to general anesthesia (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia only (group A)
Number of subjects: 60
Study: 26908424

Group type: EXPERIMENTAL
Intervention: Yogurt Kplus (enriched with MK-7, vitamins D3 and C, magnesium, n-3 PUFA, and fish oil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yogurt K (fortified with MK-7 only)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soft gel capsules containing MK-7
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yogurt Kplus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yogurt K
Number of subjects: 0

Group type: COMPARATOR
Intervention: Soft gel capsules
Number of subjects: 0